From WikiPathways

Revision as of 13:20, 6 April 2017 by Marvin M2 (Talk | contribs)
Jump to: navigation, search

The purpose of this portal is to create a collection of AOPs on the molecular level for the AOPs that are, or will be created for the EU-ToxRisk program, in which Open PHACTS Foundation (OPF) is responsible for AOP creation. The subjects of the first AOPs are linked to the use cases of the EU-ToxRisk program, and there will be a team of experts involved in the creation of each AOP.

The proposed list of the first set of AOPs to be created:

  • Inhibition of β-oxidation leads to liver steatosis
  • HDAC inhibition leads to teratogenicity
  • ROS formation leads to teratogenicity
  • Oxidative stress leads to hepatotoxicity
  • Oxidative stress leads to nephrotoxicity
  • Disturbance of the respiratory chain leads to mitotoxicity
  • PPAR activation leads to hepatoxicity
  • OAT overactivation leads to nephrotoxicity
  • PXR activation leads to liver steatosis
  • NAPQI production causes hepatotoxicity
  • MTP impairment leads to hepatotoxicity
  • CYP51 inhibition causes embryotoxicity
  • Epithelial damage leads to popcorn lung

Basic strategies and principles for general AOPs are described in this paper:

Villeneuve et al. (2014). Adverse Outcome Pathway (AOP) Development I: Strategies and Principles. Toxicological Sciences PubMed

Personal tools